“减肥神药”诺和盈上市多家平台推出在线预约服务丨新经济观察

封面新闻11-21 15:59

封面新闻记者付文超11月17日，诺和诺德公司旗下减重版司美格鲁肽注射液（诺和盈）在国内上市。作为全球首个且目前唯一的GLP-1RA（胰高糖素样肽-1受体激动剂）周制剂，诺和盈以其独特的减重机制，迅速吸引了肥胖患者及医疗行业的广泛关注，销售十分火爆，价格也一路看涨，最高售价达1700元每支。记者从京东平台了解到，这几天的销售量已近千支。记者留意到，目前包括京东在内的多家电商平台，已经推出该药的在线...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2485545931?lang=zh_CN&edition=full","thumbnail":"https://inews.gtimg.com/om_ls/OqLoElg2lo9UHtHja9U9N0-IszYqsBMx9X6IUSp6BQ4pcAA_294195/0","is_english":false,"pubTime":"2024-11-21 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485545931","market":"hk","top_or_hot":-1,"title":"“减肥神药”诺和盈上市 多家平台推出在线预约服务丨新经济观察","media":"封面新闻","content":"<div>\n<p>封面新闻记者 付文超11月17日，诺和诺德公司旗下减重版司美格鲁肽注射液（诺和盈）在国内上市。作为全球首个且目前唯一的GLP-1RA（胰高糖素样肽-1受体激动剂）周制剂，诺和盈以其独特的减重机制，迅速吸引了肥胖患者及医疗行业的广泛关注，销售十分火爆，价格也一路看涨，最高售价达1700元每支。记者从京东平台了解到，这几天的销售量已近千支。记者留意到，目前包括京东在内的多家电商平台，已经推出该药的在线...</p>\n\n<a href=\"https://new.qq.com/rain/a/20241121A05ZR700\">网页链接</a>\n\n</div>\n","source":"tencent_tech","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“减肥神药”诺和盈上市 多家平台推出在线预约服务丨新经济观察</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“减肥神药”诺和盈上市 多家平台推出在线预约服务丨新经济观察\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-21 15:59 北京时间&nbsp;&nbsp;&nbsp;<a href=https://new.qq.com/rain/a/20241121A05ZR700><strong>封面新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>封面新闻记者 付文超11月17日，诺和诺德公司旗下减重版司美格鲁肽注射液（诺和盈）在国内上市。作为全球首个且目前唯一的GLP-1RA（胰高糖素样肽-1受体激动剂）周制剂，诺和盈以其独特的减重机制，迅速吸引了肥胖患者及医疗行业的广泛关注，销售十分火爆，价格也一路看涨，最高售价达1700元每支。记者从京东平台了解到，这几天的销售量已近千支。记者留意到，目前包括京东在内的多家电商平台，已经推出该药的在线...</p>\n\n<a href=\"https://new.qq.com/rain/a/20241121A05ZR700\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4526","symbol_name":"热门中概股","start_time":0,"source_url":"https://new.qq.com/rain/a/20241121A05ZR700","article_id":"2485545931","we_media_id":null,"thumbnails":["https://inews.gtimg.com/om_ls/OqLoElg2lo9UHtHja9U9N0-IszYqsBMx9X6IUSp6BQ4pcAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241121A05ZR700","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2485545931","pubTimestamp":1732175946,"sourceInfo":{"source_id":"tencent_tech","name":"腾讯科技"},"weMediaInfo":null,"summary":"封面新闻记者 付文超11月17日，诺和诺德公司旗下减重版司美格鲁肽注射液（诺和盈）在国内上市。作为全球首个且目前唯一的GLP-1RA（胰高糖素样肽-1受体激动剂）周制剂，诺和盈以其独特的减重机制，迅速吸引了肥胖患者及医疗行业的广泛关注，销售十分火爆，价格也一路看涨，最高售价达1700元每支。记者从京东平台了解到，这几...","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4526":"热门中概股","BK4588":"碎股","BK4579":"人工智能","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","JD":"京东","BK4505":"高瓴资本持仓","BK4504":"桥水持仓","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","09618":"京东集团-SW","BK4531":"中概回港概念","LU0244354667.USD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" ACC","BK4585":"ETF&股票定投概念","LU0463099449.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","IE0008368742.USD":"首域中国增长基金I Acc","BK4558":"双十一","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK4509":"腾讯概念","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK4220":"综合零售","BK4524":"宅经济概念","LU1188198961.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) INC QV","IE00BGV7N243.SGD":"FSSA Global Emerging Markets Focus I Acc SGD"},"translate_title":"\"Weight loss magic drug\" Novo Ying is listed and multiple platforms launch online appointment services | New Economic Observation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JD":0.89,"09618":0.6},"content_text":"封面新闻记者 付文超11月17日，诺和诺德公司旗下减重版司美格鲁肽注射液（诺和盈）在国内上市。作为全球首个且目前唯一的GLP-1RA（胰高糖素样肽-1受体激动剂）周制剂，诺和盈以其独特的减重机制，迅速吸引了肥胖患者及医疗行业的广泛关注，销售十分火爆，价格也一路看涨，最高售价达1700元每支。记者从京东平台了解到，这几天的销售量已近千支。记者留意到，目前包括京东在内的多家电商平台，已经推出该药的在线预约服务，极大方便了患者用药。据悉，平台搜索“诺和盈”进入到“便民找药页面”，在这个页面中，会显示所在城市能够提供服务的线下机构。此外，各大平台还为患者提供了多种健康服务。以京东平台为例，购买诺和盈的同时，还为患者提供了用药前12项器官功能血检服务、减重医生及营养师顾问的全程用药指导，以及相对应的耗材益生菌等。记者从相关医护人员处了解到，诺和盈属于处方药，患者应前往正规医疗机构进行评估和诊断，并严格遵照医嘱服药，不建议自行用药，以免造成不良后果。【如果您有新闻线索，欢迎向我们报料，一经采纳有费用酬谢。报料微信关注：ihxdsb，报料QQ：3386405712】查看原图 74K","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485545931"}

“减肥神药”诺和盈上市 多家平台推出在线预约服务丨新经济观察

精彩评论

“减肥神药”诺和盈上市多家平台推出在线预约服务丨新经济观察